These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 18522217)

  • 1. [Putative hepatitis C virus cell receptors].
    Farafonova TE; Olenina LV; Kolesanova EF
    Biomed Khim; 2008; 54(2):154-66. PubMed ID: 18522217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential role of the heparan sulfate in the hepatitis C virus attachment.
    Heo TH
    Acta Virol; 2008; 52(1):7-15. PubMed ID: 18459830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudin-1 and its potential role in HCV entry: another piece of the puzzle.
    Hamilton JP; Thuluvath PJ
    J Clin Gastroenterol; 2008 Jan; 42(1):3-4. PubMed ID: 18097281
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C virus entry: role of host and viral factors.
    Samreen B; Khaliq S; Ashfaq UA; Khan M; Afzal N; Shahzad MA; Riaz S; Jahan S
    Infect Genet Evol; 2012 Dec; 12(8):1699-709. PubMed ID: 22878095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus entry: an intriguing challenge for drug discovery.
    Meanwell NA
    Curr Opin Investig Drugs; 2006 Aug; 7(8):727-32. PubMed ID: 16955684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Another putative receptor for hepatitis C virus.
    Op De Beeck A; Dubuisson J
    Hepatology; 2003 Mar; 37(3):705-7. PubMed ID: 12627595
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C virus entry: beyond receptors.
    Meredith LW; Wilson GK; Fletcher NF; McKeating JA
    Rev Med Virol; 2012 May; 22(3):182-93. PubMed ID: 22392805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein.
    Heo TH; Lee SM; Bartosch B; Cosset FL; Kang CY
    Virus Res; 2006 Oct; 121(1):58-64. PubMed ID: 16725222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular receptors and HCV entry.
    Flint M; Tscherne DM
    Methods Mol Biol; 2009; 510():265-77. PubMed ID: 19009268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.
    Zhao X; Tang ZY; Klumpp B; Wolff-Vorbeck G; Barth H; Levy S; von Weizsäcker F; Blum HE; Baumert TF
    J Clin Invest; 2002 Jan; 109(2):221-32. PubMed ID: 11805134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
    Perrault M; Pécheur EI
    Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interaction of the hepatitis C virus with the cellular membrane].
    Sanz-Cameno P; Borque MJ; García-Buey L; Moreno-Otero R
    Gastroenterol Hepatol; 2002 Oct; 25(8):521-5. PubMed ID: 12361536
    [No Abstract]   [Full Text] [Related]  

  • 13. The ins and outs of hepatitis C virus entry and assembly.
    Lindenbach BD; Rice CM
    Nat Rev Microbiol; 2013 Oct; 11(10):688-700. PubMed ID: 24018384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid scramblase 1 mediates hepatitis C virus entry into host cells.
    Gong Q; Cheng M; Chen H; Liu X; Si Y; Yang Y; Yuan Y; Jin C; Yang W; He F; Wang J
    FEBS Lett; 2011 Sep; 585(17):2647-52. PubMed ID: 21806988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does hepatitis C virus enter cells?
    Diedrich G
    FEBS J; 2006 Sep; 273(17):3871-85. PubMed ID: 16934030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host cell responses induced by hepatitis C virus binding.
    Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; Kreutz C; Maiwald T; Timmer J; Kern WV; Donauer J; Geyer M; Walz G; Depla E; von Weizsäcker F; Blum HE; Baumert TF
    Hepatology; 2006 Jun; 43(6):1326-36. PubMed ID: 16729312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DC-SIGN: binding receptors for hepatitis C virus.
    Wang QC; Feng ZH; Nie QH; Zhou YX
    Chin Med J (Engl); 2004 Sep; 117(9):1395-400. PubMed ID: 15377434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.
    Steinmann D; Barth H; Gissler B; Schürmann P; Adah MI; Gerlach JT; Pape GR; Depla E; Jacobs D; Maertens G; Patel AH; Inchauspé G; Liang TJ; Blum HE; Baumert TF
    J Virol; 2004 Sep; 78(17):9030-40. PubMed ID: 15308699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of tetraspanin-enriched microdomains (TEMs) in hepatitis C virus.
    Sanz-Cameno P; Martín-Vílchez S; Rodriguez-Muñoz Y; Moreno-Otero R
    Hepatology; 2008 Jul; 48(1):346-8. PubMed ID: 18521868
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection.
    Chan CM; Lau SK; Woo PC; Tse H; Zheng BJ; Chen L; Huang JD; Yuen KY
    J Virol; 2009 Jan; 83(2):1026-35. PubMed ID: 18987136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.